Skip to main navigation Skip to search Skip to main content

Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults

Matti O Ruuskanen, Pande P Erawijantari, Aki S Havulinna, Yang Liu, Guillaume Méric, Jaakko Tuomilehto, Michael Inouye, Pekka Jousilahti, Veikko Salomaa, Mohit Jain, Rob Knight, Leo Lahti, Teemu J Niiranen

Research output: Contribution to journalArticlepeer-review

87   Link opens in a new tab Citations (SciVal)

Abstract

OBJECTIVE: To examine the previously unknown long-term association between gut microbiome composition and incident type 2 diabetes in a representative population cohort.

RESEARCH DESIGN AND METHODS: We collected fecal samples from 5,572 Finns (mean age 48.7 years; 54.1% women) in 2002 who were followed up for incident type 2 diabetes until 31 December 2017. The samples were sequenced using shotgun metagenomics. We examined associations between gut microbiome composition and incident diabetes using multivariable-adjusted Cox regression models. We first used the eastern Finland subpopulation to obtain initial findings and validated these in the western Finland subpopulation.

RESULTS: Altogether, 432 cases of incident diabetes occurred over the median follow-up of 15.8 years. We detected four species and two clusters consistently associated with incident diabetes in the validation models. These four species were Clostridium citroniae (hazard ratio [HR] 1.21; 95% CI 1.04-1.42), C. bolteae (HR 1.20; 95% CI 1.04-1.39), Tyzzerella nexilis (HR 1.17; 95% CI 1.01-1.36), and Ruminococcus gnavus (HR 1.17; 95% CI 1.01-1.36). The positively associated clusters, cluster 1 (HR 1.18; 95% CI 1.02-1.38) and cluster 5 (HR 1.18; 95% CI 1.02-1.36), mostly consisted of these same species.

CONCLUSIONS: We observed robust species-level taxonomic features predictive of incident type 2 diabetes over long-term follow-up. These findings build on and extend previous mainly cross-sectional evidence and further support links between dietary habits, metabolic diseases, and type 2 diabetes that are modulated by the gut microbiome. The gut microbiome can potentially be used to improve disease prediction and uncover novel therapeutic targets for diabetes.

Original languageEnglish
Pages (from-to)811-818
Number of pages8
JournalDiabetes Care
Volume45
Issue number4
Early online date31 Jan 2022
DOIs
Publication statusPublished - 1 Apr 2022

Bibliographical note

© 2022 by the American Diabetes Association.

Acknowledgements

The authors thank all participants in the FINRISK 2002 study and Tara Schwartz for assistance with laboratory work.

Funding

This research was supported in part by grants from the Finnish Cultural Foundation, the Finnish Foundation for Cardiovascular Research, the Emil Aaltonen Foundation, the Finnish Medical Foundation, the Sigrid Juselius Foundation, and the Academy of Finland (338818 [M.O.R.], 321356 [A.S.H.], 295741 and 307127 [L.L.], and 321351 [T.J.N.]).

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Adult
  • Cohort Studies
  • Cross-Sectional Studies
  • Diabetes Mellitus, Type 2/epidemiology
  • Female
  • Finland/epidemiology
  • Gastrointestinal Microbiome/genetics
  • Humans
  • Male
  • Middle Aged

Fingerprint

Dive into the research topics of 'Gut Microbiome Composition Is Predictive of Incident Type 2 Diabetes in a Population Cohort of 5,572 Finnish Adults'. Together they form a unique fingerprint.

Cite this